BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

13868

543748

AARTIPHARM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

AARTI PHARMALABS LIMITED performance

Today’s low

Today’s high

₹ 905.00 ₹ 929.80
₹ 925.05

52 week low

52 week high

₹ 551.05 ₹ 949.50
₹ 925.05

Open Price

₹ 909.00

Prev. Close

₹ 911.55

Volume (Shares)

181866.00

Total traded value

₹ 1682.35

Upper Circuit

₹ 1093.85

Lower Circuit

₹ 729.25

info

AARTI PHARMALABS LIMITED Share Price Update

As of the latest trading session, AARTI PHARMALABS LIMITED share price is currently at ₹ 927.2, which is up by ₹ 15.65 from its previous closing. Today, the stock has fluctuated between ₹ 905.00 and ₹ 929.80. Over the past year, AARTI PHARMALABS LIMITED has achieved a return of 51.16 %. In the last month alone, the return has been 1.12 %. Read More...

Investment Returns

Over 1 Month 1.12% Over 3 Months 36.47% Over 6 Months 40.46% Over 1 Year 51.16%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

AARTI PHARMALABS LIMITED fundamentals


  • Market cap (Cr)

    8,403.60

  • P/E Ratio (TTM)

    32.65

  • Beta

    0.95

  • Book Value / share

    203.43

  • Return on equity

    13.11%

  • EPS (TTM)

    28.39

  • Dividend yield

    0.54%

  • Net profit/quarter (Cr)

    88.85

info icon alternate text
  • Market cap (Cr)

    8,400.00

  • P/E Ratio (TTM)

    32.65

  • Beta

    0.88

  • Book Value / share

    203.43

  • Return on equity

    13.11%

  • EPS (TTM)

    28.39

  • Dividend yield

    0.54%

  • Net profit/quarter (Cr)

    88.85

info icon alternate text

AARTI PHARMALABS LIMITED Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 529.62
Operating Expense 413.62
Net Profit 88.85
Net Profit Margin (%) 16.77
Earnings Per Share (EPS) 9.80
EBITDA 140.62
Effective Tax Rate (%) 21.72
Particulars DEC 2024 (Values in Cr)
Revenue 470.95
Operating Expense 386.70
Net Profit 73.52
Net Profit Margin (%) 15.61
Earnings Per Share (EPS) 8.11
EBITDA 126.92
Effective Tax Rate (%) 23.55
Particulars SEP 2024 (Values in Cr)
Revenue 377.29
Operating Expense 316.80
Net Profit 47.84
Net Profit Margin (%) 12.67
Earnings Per Share (EPS) 5.28
EBITDA 87.71
Effective Tax Rate (%) 24.59
Particulars JUN 2024 (Values in Cr)
Revenue 393.49
Operating Expense 332.37
Net Profit 47.14
Net Profit Margin (%) 11.97
Earnings Per Share (EPS) 5.20
EBITDA 85.76
Effective Tax Rate (%) 25.43
Particulars MAR 2024 (Values in Cr)
Revenue 414.82
Operating Expense 329.22
Net Profit 63.02
Net Profit Margin (%) 15.19
Earnings Per Share (EPS) 6.95
EBITDA 113.02
Effective Tax Rate (%) 30.95
Particulars MAR 2025 (Values in Cr)
Revenue 1771.35
Operating Expense 1449.50
Net Profit 257.35
Net Profit Margin (%) 14.52
Earnings Per Share (EPS) 28.39
EBITDA 441.03
Effective Tax Rate (%) 23.48
Particulars MAR 2024 (Values in Cr)
Revenue 1502.13
Operating Expense 1238.62
Net Profit 200.65
Net Profit Margin (%) 13.35
Earnings Per Share (EPS) 22.14
EBITDA 357.15
Effective Tax Rate (%) 26.90
Particulars MAR 2023 (Values in Cr)
Revenue 1511.25
Operating Expense 1279.17
Net Profit 171.73
Net Profit Margin (%) 11.36
Earnings Per Share (EPS) 18.95
EBITDA 309.62
Effective Tax Rate (%) 26.40
Particulars MAR 2022 (Values in Cr)
Revenue 941.02
Operating Expense 809.80
Net Profit 106.73
Net Profit Margin (%) 11.34
Earnings Per Share (EPS) 11.78
EBITDA 182.29
Effective Tax Rate (%) 20.18
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.18
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 193.88
ROE % 13.08
ROCE % 16.60
Total Debt to Total Equity 0.15
EBITDA Margin 21.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 171.97
ROE % 13.14
ROCE % 16.07
Total Debt to Total Equity 0.19
EBITDA Margin 17.70
Particulars MAR 2022 (Values in Cr)
Book Value / Share 53646.60
ROE % 17.63
ROCE % 19.37
Total Debt to Total Equity 0.25
EBITDA Margin 17.46
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.12
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.09
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 178.92
ROE % 13.11
ROCE % 16.40
Total Debt to Total Equity 0.16
EBITDA Margin 23.78
Particulars MAR 2023 (Values in Cr)
Book Value / Share 158.74
ROE % 12.61
ROCE % 15.56
Total Debt to Total Equity 0.20
EBITDA Margin 20.49
Particulars MAR 2022 (Values in Cr)
Book Value / Share 49558.52
ROE % 16.62
ROCE % 18.00
Total Debt to Total Equity 0.25
EBITDA Margin 19.37
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.07
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 24.06
Total Assets 2582.10
Total Liabilities 2582.10
Total Equity 1757.03
Share Outstanding 90626008
Price to Book Ratio 2.43
Return on Assets (%) 8.40
Return on Capital (%) 10.73
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 12.19
Total Assets 2244.02
Total Liabilities 2244.02
Total Equity 1558.48
Share Outstanding 90626008
Price to Book Ratio 1.73
Return on Assets (%) 8.62
Return on Capital (%) 10.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 83.27
Total Assets 2039.89
Total Liabilities 2039.89
Total Equity 1386.47
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) 5.99
Return on Capital (%) 7.09
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.22
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -1.83
Return on Capital (%) -1.87
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.42
Total Assets 2296.91
Total Liabilities 2296.91
Total Equity 1621.45
Share Outstanding 90626008
Price to Book Ratio 2.43
Return on Assets (%) 8.73
Return on Capital (%) 10.72
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.37
Total Assets 1976.36
Total Liabilities 1976.36
Total Equity 1438.57
Share Outstanding 90626008
Price to Book Ratio 1.73
Return on Assets (%) 8.68
Return on Capital (%) 10.44
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 56.49
Total Assets 1826.83
Total Liabilities 1826.83
Total Equity 1284.27
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) 5.84
Return on Capital (%) 6.63
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.22
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -1.83
Return on Capital (%) -2.03
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.23
Share Outstanding 250000
Price to Book Ratio 0.00
Return on Assets (%) -7.47
Return on Capital (%) -8.07
Particulars MAR 2024 (Values in Cr)
Net Income 300.49
Cash from Operations 273.29
Cash from Investing -214.56
Cash from Financing 9.72
Net change in Cash 11.51
Free Cash Flow 428.89
Particulars MAR 2023 (Values in Cr)
Net Income 260.77
Cash from Operations 312.49
Cash from Investing -157.80
Cash from Financing -163.46
Net change in Cash -71.15
Free Cash Flow 414.62
Particulars MAR 2022 (Values in Cr)
Net Income 155.38
Cash from Operations -22.57
Cash from Investing -138.73
Cash from Financing 260.38
Net change in Cash 77.94
Free Cash Flow 118.57
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2024 (Values in Cr)
Net Income 274.51
Cash from Operations 230.68
Cash from Investing -184.39
Cash from Financing 4.39
Net change in Cash 3.69
Free Cash Flow 376.64
Particulars MAR 2023 (Values in Cr)
Net Income 233.35
Cash from Operations 272.61
Cash from Investing -115.55
Cash from Financing -156.52
Net change in Cash -56.19
Free Cash Flow 371.53
Particulars MAR 2022 (Values in Cr)
Net Income 133.72
Cash from Operations -49.84
Cash from Investing -133.53
Cash from Financing 254.62
Net change in Cash 56.24
Free Cash Flow 86.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.00
Cash from Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2020 (Values in Cr)
Net Income -0.01
Cash from Operations -0.01
Cash from Investing 0.00
Cash from Financing 0.26
Net change in Cash 0.25
Free Cash Flow -0.01
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.16 32.00 1.97 277.11 34.11 / 77.70
BLISS GVS PHARMA LTD 153.75 19.24 1.54 1621.22 105.05 / 184.95
CIPLA LTD 1485.05 23.31 3.84 119948.65 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 384.45 14.72 3.11 1131.47 194.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.16 92.72 5.71 277.11 34.11 / 77.70
AMRUTAJAN HEALTH LTD 726.25 41.31 6.42 2099.63 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 9237.05 131.92 29.97 23092.63 6222.35 / 10653.05
BLISS GVS PHARMA LTD 153.75 23.51 1.53 1621.22 105.05 / 184.95

AARTI PHARMALABS LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
927.20 1.71 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 914.60
  • 26 Days 889.00
  • 10 Days 906.00
  • 50 Days 860.60
  • 12 Days 903.40
  • 100 Days 809.70
  • 20 Days 895.10
  • 200 Days 741.20
913.93 PIVOT

First Support

903.92

First Resistance

921.57

Second Support

896.28

Second Resistance

931.58

Third Support

886.27

Third Resistance

939.22

RSI

61.50

ADX

16.46

MACD

14.35

Williams % R

-5.96

Commodity Channel Index (CCI)

109.08

Date

2025-07-11

Week

140668.00

Same Day

118720.00

Month

143388.00

1 Year

0.95

3 Year

0.91

Over 1 Month

1.12%

down

Over 1 Year

51.16%

down

Over 3 Months

36.47%

down

Over 3 Years

47.61%

down

Over 6 Months

40.46%

down

Over 5 Years

0.00%

down

AARTI PHARMALABS LIMITED shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
40.81%
Promoter Holdings
44.28%
FII
7.35%
DII
7.53%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Life Insurance Corporation Of India 5490515.0 (6.06%) Public Shareholding
Rashesh Chandrakant Gogri 3834404.0 (4.23%) Shareholding of Promoter and Promoter Group
Jaya Chandrakant Gogri 3204310.0 (3.54%) Shareholding of Promoter and Promoter Group
Anushakti Enterprise Private Limited 2992950.0 (3.3%) Shareholding of Promoter and Promoter Group
Labdhi Business Trust (saswat Trusteeship Private Limited) 2841504.0 (3.14%) Shareholding of Promoter and Promoter Group
Mirik Rajendra Gogri 2793094.0 (3.08%) Shareholding of Promoter and Promoter Group
Hetal Gogri Gala 2615548.0 (2.89%) Shareholding of Promoter and Promoter Group
Renil Rajendra Gogri 2542750.0 (2.81%) Shareholding of Promoter and Promoter Group
Sarla Shantilal Shah 2435830.0 (2.69%) Shareholding of Promoter and Promoter Group
Ntasain Discovery Master Fund 2000000.0 (2.21%) Public Shareholding
Safechem Enterprises Private Limited 1463000.0 (1.61%) Shareholding of Promoter and Promoter Group
Rajendra Vallabhaji Gogri 1425900.0 (1.57%) Shareholding of Promoter and Promoter Group
Manomaya Business Trust (alabhya Trusteeship Private Limited) 1308496.0 (1.44%) Shareholding of Promoter and Promoter Group
Nehal Garewal 1122487.0 (1.24%) Shareholding of Promoter and Promoter Group
Nishant Pradip Shah 997427.0 (1.1%) Public Shareholding
Heena Family Private Trust (barclays Wealth Trustees India Private Limited) 833859.0 (0.92%) Shareholding of Promoter and Promoter Group
Bhavna Family Private Trust (barclays Wealth Trustees India Pvt Ltd) 804101.0 (0.89%) Shareholding of Promoter and Promoter Group
Nikhil Parimal Desai 716754.0 (0.79%) Shareholding of Promoter and Promoter Group
Tulip Family Trust (gloire Trusteeship Services Private Limited) 707500.0 (0.78%) Shareholding of Promoter and Promoter Group
Jasmine Family Trust (relacion Trusteeship Services Private Limited) 687500.0 (0.76%) Shareholding of Promoter and Promoter Group
Orchid Family Trust (relacion Trusteeship Services Private Limited) 680000.0 (0.75%) Shareholding of Promoter and Promoter Group
Alchemie Financial Services Limited 673006.0 (0.74%) Shareholding of Promoter and Promoter Group
Lotus Family Trust (gloire Trusteeship Services Private Limited) 624500.0 (0.69%) Shareholding of Promoter and Promoter Group
Manisha Rashesh Gogri 550000.0 (0.61%) Shareholding of Promoter and Promoter Group
Aashay Rashesh Gogri 550000.0 (0.61%) Shareholding of Promoter and Promoter Group
Aarnav Rashesh Gogri 550000.0 (0.61%) Shareholding of Promoter and Promoter Group
Arti Rajendra Gogri 455256.0 (0.5%) Shareholding of Promoter and Promoter Group
Parimal Hasmukhlal Desai 349571.0 (0.39%) Shareholding of Promoter and Promoter Group
Ratanben Premji Gogri 344332.0 (0.38%) Shareholding of Promoter and Promoter Group
Gogri Finserv Pvt. Ltd. 337505.0 (0.37%) Shareholding of Promoter and Promoter Group
Heena Bhatia 322588.0 (0.36%) Shareholding of Promoter and Promoter Group
Rajendra Vallabhaji Gogri (huf) [karta-rajendra Vallabhaji Gogri] 308274.0 (0.34%) Shareholding of Promoter and Promoter Group
Shantilal Tejshi Shah (huf)[karta-nehal Garewal] 278881.0 (0.31%) Shareholding of Promoter and Promoter Group
Alchemie Finserv Pvt. Ltd. 264105.0 (0.29%) Shareholding of Promoter and Promoter Group
Nikhil Holdings Private Limited 180891.0 (0.2%) Shareholding of Promoter and Promoter Group
Indira Madan Dedhia 182250.0 (0.2%) Shareholding of Promoter and Promoter Group
Mananjay Singh Garewal 162510.0 (0.18%) Shareholding of Promoter and Promoter Group
Bhanu Pradip Savla 155737.0 (0.17%) Shareholding of Promoter and Promoter Group
Hetvi Rohan Ghalla 150000.0 (0.17%) Shareholding of Promoter and Promoter Group
Chandrakant Vallabhaji Gogri 155500.0 (0.17%) Shareholding of Promoter and Promoter Group
Monisha Bhatia 121121.0 (0.13%) Shareholding of Promoter and Promoter Group
Shreya Suneja 112500.0 (0.12%) Shareholding of Promoter and Promoter Group
Dinesh Devchand Ghalla 100000.0 (0.11%) Shareholding of Promoter and Promoter Group
Gunavanti Navin Shah 86644.0 (0.1%) Shareholding of Promoter and Promoter Group
Krisha Yogesh Nahar 42740.0 (0.05%) Shareholding of Promoter and Promoter Group
Aashyav Business Trust (alabhya Trusteeship Private Limited) 37900.0 (0.04%) Shareholding of Promoter and Promoter Group
Jayesh Shah 14957.0 (0.02%) Shareholding of Promoter and Promoter Group
Valiant Organics Limited 7500.0 (0.01%) Shareholding of Promoter and Promoter Group
Dilesh Roadlines Pvt Ltd 8318.0 (0.01%) Shareholding of Promoter and Promoter Group
Tarla Parimal Desai 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Pooja Renil Gogri 382.0 (0.0%) Shareholding of Promoter and Promoter Group
Prasadi Yogesh Banatwala 4245.0 (0.0%) Shareholding of Promoter and Promoter Group
Bhavna Shah Lalka 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

AARTI PHARMALABS LIMITED corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
14 Feb 2025 2.5 Interim 14 Feb 2025 Equity shares
31 Jul 2024 1.0 Final 31 Jul 2024 Equity shares
16 Feb 2024 2.0 Interim 19 Feb 2024 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
14 Feb 2025 2.5 Interim 14 Feb 2025 Equity shares
31 Jul 2024 1.0 Final 31 Jul 2024 Equity shares
16 Feb 2024 2.0 Interim 19 Feb 2024 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

AARTI PHARMALABS LIMITED Share Price

Aarti Pharmachem Limited, formerly known as Aarti Organics Limited, was incorporated as a Public Limited Company in 2019. The Company changed the name from Aarti Organics Limited to Aarti Pharmachem Limited on July 1, 2021. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine derivatives situated in India. It specialise in developing and manufacturing Highly Potent Active Pharmaceutical Ingredients (HPAPIs) critical for various therapeutic segments such as Anti-cancer, Anti-Asthma, Anti-Hypertensive etc.

In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.

The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.

Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.

The R&D centre in Nerul, Navi Mumbai became fully operational in FY 2024. The Company has commenced operations for its semi-commercial block at the USFDA intermediate manufacturing site in Vapi in FY24. The Xanthine capacity was enhanced to 5000 TPA in 2023-24.

Parent organization Indian Private
NSE symbol AARTIPHARM
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Aarti Pharmalabs Ltd?

Answer Field

Aarti Pharmalabs Ltd share price is for NSE ₹ 927.20 & for BSE ₹ 923.00 as on Jul 11 2025 03:30 PM.

What is the Market Cap of Aarti Pharmalabs Ltd Share?

Answer Field

The market cap of Aarti Pharmalabs Ltd for NSE ₹ 8,402.84 & for BSE ₹ 8,364.78 as on Jul 11 2025 03:30 PM.

What is the 52 Week High and Low of Aarti Pharmalabs Ltd?

Answer Field

The 52 Week High and Low of Aarti Pharmalabs Ltd for NSE is ₹ 949.50 and ₹ 551.05 and for BSE is ₹ 948.80 and ₹ 521.00.

What is 1 year return for Aarti Pharmalabs Ltd?

Answer Field

The 1 year returns on the stock has been 51.16%.

What is the P/E Ratio of Aarti Pharmalabs Ltd Share?

Answer Field

As on Jul 11 2025 03:30 PM the price-to-earnings (PE) ratio for Aarti Pharmalabs Ltd share is 32.65.

What is the PB ratio of Aarti Pharmalabs Ltd Share?

Answer Field

As on Jul 11 2025 03:30 PM, the price-to-book (PB) ratio for Aarti Pharmalabs Ltd share is 203.43.

How to Buy Aarti Pharmalabs Ltd Share?

Answer Field

You can trade in Aarti Pharmalabs Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Aarti Pharmalabs Ltd Share on Bajaj Broking App?

Answer Field

To buy Aarti Pharmalabs Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Aarti Pharmalabs Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|